The provision was approved by the U.S. House of Representatives' Appropriations Committee.
Lupus organizations announce groundbreaking collaborative initiative to inform lupus drug development.
Lupus Organizations Continue Collaborating to Spark Innovation and Scientific Advances in Lupus Research
Through a rigorous peer-review process, the Foundation will fund the most promising research focused on improving the quality of life for people with lupus.
The research plan identifies and examines opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies
10th Anniversary of the Evelyn V. Hess Award Celebrates Past Honorees
Eight LFA-supported research studies presented during the American College of Rheumatology Annual Scientific Meeting
Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO